Credits Available: 4.75 hours of AMA PRA Category 1 Credit™ with ABIM MOC

Description: This curriculum is designed to enhance knowledge, competence, and confidence among oncology clinicians regarding second-line therapy for small cell lung cancer (SCLC). Learners will explore evidence-based treatment sequencing, adverse event management, and emerging clinical trial data to optimize patient outcomes.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse, Nurse Practitioner, Physician Associate/Assistant
Target Specialties: Oncology, Hematology/Oncology

Erin Eickman

Northside Hospital Cancer Institute
Clinical Oncology Pharmacist

Dr. Erin Eickman is a clinical oncology pharmacist specializing in solid tumors and precision medicine. She obtained her Doctor of Pharmacy (PharmD) degree from the University of Nebraska Medical Center. After graduation, she pursued residency training completing her PGY1 at St. Joseph's/Candler Health System in Savannah, GA followed by a PGY2 Oncology Residency at Geisinger Medical Center in Danville, PA. Dr. Eickman currently works at Northside Hospital in Atlanta, GA as a clinical oncology pharmacist covering all solid tumors. She also specializes in precision medicine through her leading role on the Northside Hospital Cancer Institute's Genomic Oncology Advisory Board (GOAB).